CME
CME Group Inc.
CME has slightly lower modeled downside risk, despite its lower overall score.
SOFI
SoFi Technologies, Inc.
SOFI has the edge over CME overall, supported by stronger modeled upside and stronger valuation.
CME Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
CME's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CME.
SOFI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| N/A | |
| N/A |
SOFI's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like SOFI.
CME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 24x | $289 | -8.3% |
| Forward | 24x | $316 | — |
| Fair | 26x | $314 | -0.4% |
| Current | 26x | $316 | — |
| Expensive | 33x | $405 | +28% |
Historical ranges are pointers, not guarantees.
CME's PE is 26x, but its earnings don't support one, so it isn't a reliable read right now.
SOFI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $15.63 | — |
| Current | 28x | $15.63 | — |
| Cheap | 33x | $18.24 | +17% |
| Fair | 43x | $23.82 | +52% |
| Expensive | 53x | $29.74 | +90% |
Historical ranges are pointers, not guarantees.
SOFI has the edge over CME in the historical PE scenario, which offers more potential upside but is not a forecast.
CME Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CME, with profitability improving.
SOFI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for SOFI, with profitability improving.
CME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.95 | +6.2% |
| Q3 2026 | $12.19 | +18% |
| Q2 2026 | $11.79 | +14% |
| Q1 2026 | $11.72 | +18% |
| Q4 2025 | $11.16 | +15% |
| Q3 2025 | $10.32 | +8.6% |
| Q2 2025 | $10.33 | +14% |
| Q1 2025 | $9.94 | +13% |
| Q4 2024 | $9.67 | +9.1% |
CME has the edge over SOFI on earnings, with more consistent year-over-year improvement.
SOFI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | +47% |
| Q3 2026 | $0.56 | 0% |
| Q2 2026 | $0.49 | -2% |
| Q1 2026 | $0.45 | +4.7% |
| Q4 2025 | $0.39 | 0% |
| Q3 2025 | $0.56 | +367% |
| Q2 2025 | $0.50 | +$0.72 |
| Q1 2025 | $0.43 | +$0.72 |
| Q4 2024 | $0.39 | +$0.75 |
SOFI earned $0.56 per share over the past year, about the same as the year before.
CME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +13% |
| Q2 2026 | $1.7B | +0.8% |
| Q1 2026 | $1.9B | +14% |
| Q4 2025 | $1.6B | +8.1% |
| Q3 2025 | $1.5B | -3% |
| Q2 2025 | $1.7B | +10% |
| Q1 2025 | $1.6B | +10% |
| Q4 2024 | $1.5B | +6% |
CME's revenue has grown year over year for four quarters in a row: $1.7B last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +2.5 points |
| Q2 2026 | 65% | -1.8 points |
| Q1 2026 | 70% | +2.2 points |
| Q4 2025 | 62% | -0.3 points |
| Q3 2025 | 63% | -1.4 points |
| Q2 2025 | 67% | +1.4 points |
| Q1 2025 | 67% | +3 points |
| Q4 2024 | 62% | +2.1 points |
CME has the edge over SOFI on profitability, with a higher operating margin.
SOFI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +44% |
| Q2 2026 | $1.2B | +43% |
| Q1 2026 | $1.1B | +43% |
| Q4 2025 | $1B | +40% |
| Q3 2025 | $961.6M | +38% |
| Q2 2025 | $854.9M | +43% |
| Q1 2025 | $771.8M | +20% |
| Q4 2024 | $734.1M | +19% |
SOFI has the edge over CME on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +7.5 points |
| Q2 2026 | 17% | +3.6 points |
| Q1 2026 | 18% | +7.8 points |
| Q4 2025 | 18% | +9.9 points |
| Q3 2025 | 15% | +6.3 points |
| Q2 2025 | 13% | +11 points |
| Q1 2025 | 10% | -4.3 points |
| Q4 2024 | 8.2% | -0.2 points |
SOFI's operating margin was 23% last quarter, up 7.5 points from the same quarter a year ago, near the top of its range since 2021.
CME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +13% |
| Q2 2026 | $923.5M | -11% |
| Q1 2026 | $1.2B | +12% |
| Q4 2025 | $1.1B | +11% |
| Q3 2025 | $949.7M | -2.4% |
| Q2 2025 | $1B | +37% |
| Q1 2025 | $1.1B | +26% |
| Q4 2024 | $991.7M | -3.1% |
CME has the edge over SOFI on cash generation, producing positive trailing cash flow while its opponent burns cash.
SOFI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.1B | -$1.7B |
| Q2 2026 | -$4B | -$2.5B |
| Q1 2026 | -$2.4B | -$2.4B |
| Q4 2025 | -$1.1B | -$815.2M |
| Q3 2025 | -$1.4B | -$149M |
| Q2 2025 | -$1.5B | -$1B |
| Q1 2025 | -$31.1M | -104% |
| Q4 2024 | -$242.4M | +$39.9M |
SOFI's free cash flow was −$10.5B over the past year, against −$3.2B the year before. Free cash flow isn't a meaningful measure for financial services companies like SOFI.
CME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -2.6M shares |
| 1 year | -0.5% | -1.8M shares |
| 3 years | -0.3% | -978K shares |
| 5 years | -0.1% | -347K shares |
| Available history | +0.1% | +402K shares |
CME has the edge over SOFI on shareholder dilution, with a more favorable share count trend.
SOFI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +5.8M shares |
| 1 year | +5.2% | +66.8M shares |
| 3 years | +43% | +407M shares |
| 5 years | +272% | +993M shares |
SOFI has 1.4B diluted shares, up 5.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
CME Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2020 | -0.4x | Net Cash |
| Q2 2020 | -0.4x | Net Cash |
| Q1 2020 | -0.3x | Net Cash |
| Q4 2019 | -0.6x | Net Cash |
CME has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like CME.
SOFI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.4x | Net Cash |
| Q2 2026 | -3.1x | Net Cash |
| Q1 2026 | -3.8x | Net Cash |
| Q4 2025 | -6.5x | Net Cash |
| Q3 2025 | -5.2x | Net Cash |
| Q2 2025 | -4.0x | Net Cash |
| Q1 2025 | -4.9x | Net Cash |
| Q4 2024 | -5.8x | Net Cash |
SOFI has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like SOFI.
CME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.2 | Neutral |
| Stochastic | 89.3 | Overbought |
CME's weekly RSI is 65 (neutral) and its Stochastic is 89 (overbought).
SOFI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.1 | Neutral |
| Stochastic | 41.5 | Neutral |
SOFI's weekly RSI is 43 (neutral) and its Stochastic is 41 (neutral).
CME PE vs Financial Services Sector
| Metric | CME | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 13x | 99% above |
| PE % | 51 | 63 | 12 pts below |
CME has the edge over SOFI on valuation relative to its sector.
SOFI PE vs Financial Services Sector
| Metric | SOFI | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 114% above |
| PE % | 2 | 61 | 59 pts below |
SOFI is trading at 28x earnings, a 114% premium to the Financial Services sector's median of 13x.
CME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $291.5 | 8.2% above |
| 20 week MA | $275.2 | 15% above |
| 50 week MA | $280.9 | 12% above |
| 100 week MA | $272.5 | 16% above |
| 200 week MA | $238.3 | 32% above |
CME has the edge over SOFI on trend strength, trading above more of its moving averages.
SOFI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.7 | 0.7% below |
| 20 week MA | $17.0 | 7.8% below |
| 50 week MA | $18.9 | 17% below |
| 100 week MA | $18.9 | 17% below |
| 200 week MA | $13.5 | 16% above |
SOFI has fallen below most of its moving averages, though it's still 16% above its 200-week average.
CME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $202.8 | $178.5 | -12% |
| 2021 | $178.5 | $229.0 | +28% |
| 2022 | $229.0 | $173.3 | -24% |
| 2023 | $173.3 | $210.6 | +22% |
| 2024 | $210.6 | $233.5 | +11% |
| 2025 | $233.5 | $276.7 | +19% |
| 2026 YTD | $276.7 | $315.5 | +14% |
CME has the edge over SOFI on returns for 2026, with the stronger performance.
SOFI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.4 | $12.4 | +19% |
| 2021 | $12.4 | $15.1 | +22% |
| 2022 | $15.1 | $4.61 | -69% |
| 2023 | $4.61 | $9.95 | +116% |
| 2024 | $9.95 | $16.0 | +61% |
| 2025 | $16.0 | $27.1 | +69% |
| 2026 YTD | $27.1 | $15.6 | -42% |
SOFI's yearly returns have swung widely, from +116% in 2023 to −69% in 2022. It's down 42% so far in 2026.